ELVN
Enliven Therapeutics Inc.
45.20$
-2.0%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| – | -24.6% | +332.2% | +172.8% | +24.8% | -26.5% | +226.4% | +19.8% | +46.2% | |
| – | -24.6% | +297.5% | +195.2% | +22.4% | -29.7% | +242.3% | +19.5% | +49.3% | |
| – | -23.7% | -33.1% | +866.3% | +130.7% | -31.3% | +32.6% | +23.9% | -20.3% | |
| – | -23.7% | +291.6% | +205.2% | +24.7% | -31.3% | +235.1% | +23.8% | +47.6% | |
| – | – | – | – | +129.3% | – | – | – | – | |
| – | +23.3% | +139.2% | +46.2% | +0.9% | +2,376.0% | -83.8% | -38.7% | +4.8% | |
| – | +121.8% | +129.1% | +48.8% | -7.9% | +68.9% | +166.5% | -38.5% | +4.1% | |
| – | – | – | – | +51.4% | +103.1% | +3.7% | – | – | |
| – | +110.7% | +82.6% | +18.9% | +27.9% | +36.4% | -84.5% | +152.3% | +60.9% | |
| – | – | – | – | +26.6% | -171.9% | – | +26.0% | +48.3% | |
| – | – | – | – | – | – | – | – | – | |
| – | +0.0% | +0.0% | +1.6% | +78.0% | -20.0% | +468.8% | +32.4% | +20.4% |
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.